These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 31981856)

  • 21. Effects of Low-Dose Ketamine on the Antidepressant Efficacy and Suicidal Ideations in Patients Undergoing Electroconvulsive Therapy.
    Chen Q; Dong J; Luo J; Ren L; Min S; Hao X; Luo Q; Chen J; Li X
    J ECT; 2020 Mar; 36(1):25-30. PubMed ID: 31913927
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neuropsychological and mood effects of ketamine in electroconvulsive therapy: a randomised controlled trial.
    Loo CK; Katalinic N; Garfield JB; Sainsbury K; Hadzi-Pavlovic D; Mac-Pherson R
    J Affect Disord; 2012 Dec; 142(1-3):233-40. PubMed ID: 22858219
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rapid antidepressant effect of ketamine in the electroconvulsive therapy setting.
    Abdallah CG; Fasula M; Kelmendi B; Sanacora G; Ostroff R
    J ECT; 2012 Sep; 28(3):157-61. PubMed ID: 22847373
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neurocognitive performance of repeated versus single intravenous subanesthetic ketamine in treatment resistant depression.
    Shiroma PR; Thuras P; Wels J; Albott CS; Erbes C; Tye S; Lim KO
    J Affect Disord; 2020 Dec; 277():470-477. PubMed ID: 32871534
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ketamine and other glutamate receptor modulators for depression in adults.
    Caddy C; Amit BH; McCloud TL; Rendell JM; Furukawa TA; McShane R; Hawton K; Cipriani A
    Cochrane Database Syst Rev; 2015 Sep; (9):CD011612. PubMed ID: 26395901
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ketamine and electroconvulsive therapy: so happy together?
    Cobb K; Nanda M
    Curr Opin Anaesthesiol; 2018 Aug; 31(4):459-462. PubMed ID: 29794567
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A randomized, crossover comparison of ketamine and electroconvulsive therapy for treatment of major depressive episodes: a Canadian biomarker integration network in depression (CAN-BIND) study protocol.
    Phillips JL; Jaworska N; Kamler E; Bhat V; Blier J; Foster JA; Hassel S; Ho K; McMurray L; Milev R; Moazamigoudarzi Z; Placenza FM; Richard-Devantoy S; Rotzinger S; Turecki G; Vazquez GH; Kennedy SH; Blier P;
    BMC Psychiatry; 2020 Jun; 20(1):268. PubMed ID: 32487236
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ketamine as the anaesthetic for electroconvulsive therapy: the KANECT randomised controlled trial.
    Fernie G; Currie J; Perrin JS; Stewart CA; Anderson V; Bennett DM; Hay S; Reid IC
    Br J Psychiatry; 2017 Jun; 210(6):422-428. PubMed ID: 28254962
    [No Abstract]   [Full Text] [Related]  

  • 29. Ketamine plus propofol-electroconvulsive therapy (ECT) transiently improves the antidepressant effects and the associated brain functional alterations in patients with propofol-ECT-resistant depression.
    Zhang J; Tian H; Li J; Ji S; Chen S; Zhu J; Jiang D; Wang L; Li G; Chen M; Wang W; Lin X; Zhuo C
    Psychiatry Res; 2020 May; 287():112907. PubMed ID: 32179210
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Ketamine's antidepressant effect: literature review on clinical use].
    De Maricourt P; Jay T; Goncalvès P; Lôo H; Gaillard R
    Encephale; 2014 Feb; 40(1):15-23. PubMed ID: 24434008
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Administration of Sub-anesthetic Dose of Ketamine and Electroconvulsive Treatment on Alternate Week Days in Patients with Treatment Resistant Depression: A Double Blind Placebo Controlled Trial.
    Altinay M; Karne H; Anand A
    Psychopharmacol Bull; 2019 Feb; 49(1):8-16. PubMed ID: 30858635
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neurocognitive effects of repeated ketamine infusion treatments in patients with treatment resistant depression: a retrospective chart review.
    Dai D; Miller C; Valdivia V; Boyle B; Bolton P; Li S; Seiner S; Meisner R
    BMC Psychiatry; 2022 Feb; 22(1):140. PubMed ID: 35193541
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of Ketamine Anesthesia on Efficacy, Tolerability, Seizure Response, and Neurocognitive Outcomes in Electroconvulsive Therapy: A Comprehensive Meta-analysis of Double-Blind Randomized Controlled Trials.
    Ainsworth NJ; Sepehry AA; Vila-Rodriguez F
    J ECT; 2020 Jun; 36(2):94-105. PubMed ID: 31725054
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A randomized clinical trial of adjunctive ketamine anesthesia in electro-convulsive therapy for depression.
    Zhang M; Rosenheck R; Lin X; Li Q; Zhou Y; Xiao Y; Huang X; Fan N; He H
    J Affect Disord; 2018 Feb; 227():372-378. PubMed ID: 29149755
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Kynurenine pathway metabolism and the neurobiology of treatment-resistant depression: Comparison of multiple ketamine infusions and electroconvulsive therapy.
    Allen AP; Naughton M; Dowling J; Walsh A; O'Shea R; Shorten G; Scott L; McLoughlin DM; Cryan JF; Clarke G; Dinan TG
    J Psychiatr Res; 2018 May; 100():24-32. PubMed ID: 29475018
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mood and neuropsychological effects of different doses of ketamine in electroconvulsive therapy for treatment-resistant depression.
    Zhong X; He H; Zhang C; Wang Z; Jiang M; Li Q; Zhang M; Huang X
    J Affect Disord; 2016 Sep; 201():124-30. PubMed ID: 27208499
    [TBL] [Abstract][Full Text] [Related]  

  • 37. KETAMINE FOR TREATMENT-RESISTANT UNIPOLAR AND BIPOLAR MAJOR DEPRESSION: CRITICAL REVIEW AND IMPLICATIONS FOR CLINICAL PRACTICE.
    Bobo WV; Vande Voort JL; Croarkin PE; Leung JG; Tye SJ; Frye MA
    Depress Anxiety; 2016 Aug; 33(8):698-710. PubMed ID: 27062450
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Short- and long-term neurocognitive functioning after electroconvulsive therapy in depressed elderly: a prospective naturalistic study.
    Verwijk E; Comijs HC; Kok RM; Spaans HP; Tielkes CE; Scherder EJ; Stek ML
    Int Psychogeriatr; 2014 Feb; 26(2):315-24. PubMed ID: 24280446
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neurocognitive effects of ketamine and association with antidepressant response in individuals with treatment-resistant depression: a randomized controlled trial.
    Murrough JW; Burdick KE; Levitch CF; Perez AM; Brallier JW; Chang LC; Foulkes A; Charney DS; Mathew SJ; Iosifescu DV
    Neuropsychopharmacology; 2015 Mar; 40(5):1084-90. PubMed ID: 25374095
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Adjunctive ketamine and electroconvulsive therapy for major depressive disorder: A meta-analysis of randomized controlled trials.
    Zheng W; Li XH; Zhu XM; Cai DB; Yang XH; Ungvari GS; Ng CH; Ning YP; Hu YD; He SH; Wang G; Xiang YT
    J Affect Disord; 2019 May; 250():123-131. PubMed ID: 30852364
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.